Current Research

- Physical fitness as an objective biomarker for AD/ADRD risk modification.

- Identification of Targetable Prostate Cancer Alterations Through Tumor DNA Screening.

1. 1/2 Doxycycline for Emphysema in People Living with HIV: The DEPTH Trial.

1. ANT007: A multicenter, randomized, open-label, blinded endpoint evaluation, phase 3 study comparing the effect of abelacimab relative to apixaban on venous thromboembolism (VTE) recurrence and bleeding in patients with cancer associated VTE (ASTER).

1. Calcium transport in kidney proximal tubule and calcium phosphate stone formation.

1. City-wide DC cohort of HIV infected persons in care in the District of Columbia.

1. Participant and Clinical (PCI) and Intergrating special Populations (ISP) (HLT/HUB).

1. Cerebrovascular reactivity and oxygen metabolism as markers of neurodegeneration after traumatic brain injury.

1. Advancing High Quality COPD care for people with immune dysfunction by implementing evidence based management through proactive E- Consults (ACHIEVE).

1. A Randomized Controlled Trial of Alternating Irrigation of Vancomycin HCl and Tobramycin Sulfate in Patients Undergoing Two-Stage Exchange Arthroplasty for Periprosthetic Joint Infection of Hip or Knee.

1. FLU 003 Plus (Zrespiratory Virus Hospitalization Study, INSIGHT Protocol No. 003) and FLU 004 (Genomics).

1. Identifying Novel Biomarkers of Disease Progression in Rheumatoid Arthritis-Associated Interstitial Lung Disease.

1. Towards treatment for the complex patient: investigations of low-intensity focused ultrasound.

1. An International Prospective Open-label, Randomized, Phase III Study comparing 177Lu-PSMA-617 in combination with Standard of Care, versus Standard of Care alone, in adult male patients with Metastatic Hormone Sensitive Prostate Cancer (mHSPC).

1. A Randomized, Open-Label Phase 2/3 Study Comparing Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone In Participants with Advanced Nonsmall Cell Lung Cancer Who have Progressed on prior Anti-PD-(L)1 Therapy and Chemotherapy (COSTAR LUNG).

1. Veterans Affairs (VA) Lipid Optimization Reimagined (VALOR-QI) in Veterans with Atherosclerotic Cardiovascular Disease (ASCVD) VA Multisite Project. (Project).

1. Effect of HIV medications on cardiometabolic health in African American Veterans.

1. Urinary Proadrenomedullin to improve risk stratification of children with community-acquired pneumonia.

1. The TARGET BP I Trial: A Pivotal, Multicenter, Blinded, Sham-Procedure-Controlled Trial of Renal Denervation by the Peregrine™ System Kit, in Subjects with Hypertension.

1. Vectra InVolved Informed Decision Outcome Study (VIVID): A prospective randomized controlled trial evaluating the effect of guided care with Vectra on compared to treatment as usual in patients with rheumatoid arthritis.

1. Study to test the safety and dose of proglumide as an antifibrotic agent in Non alcoholic steatohepatitis. closed

1. Role of Empagliflozin in African American Veterans with Non-Diabetic Chronic Kidney Disease.

1. A Multicenter, Randomized, Double-Blind, Parallel Group, PlaceboControlled Trial to Evaluate the Effect of In-Hospital Initiation of Dapagliflozin on Clinical Outcomes in Patients with Heart Failure with Reduced Ejection Fraction Who Have Been Stabilized During Hospitalization for Acute Heart Failure.

1. A primary role for the circulatory microenvironment in African American prostate cancer disparities.

1. Long-Term Outcomes of Antipsychotic Medication Use in Veterans with PTSD.

1. Risk Factors for Preclinical MS:  The ENGEMS Cohort- Genetic and Environmental Risk Factors for Multiple Sclerosis.

1. Identification of Targetable Prostate Cancer Alterations Through Tumor DNA Screening.

1. Randomized, placebo-controlled cross-over trial evaluating topical lidocaine patches for mechanical neck pain.